Boardroom Alpha
Meeting calendar
HLI · Annual meeting · Wednesday, September 17, 2025

Houlihan Lokey Inc

3 nominees · 3 ballot items.

Election of three Class I directors, advisory vote on executive compensation, and ratification of KPMG LLP as independent auditor.

Market cap
$9.5B
1Y TSR
-19.9%
Board grade
B-
Record date
Jul 24, 2025
Filing
DEF 14A
Meeting concluded · Sep 17, 2025

Follow how the vote landed and what changed on Houlihan Lokey Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.

Proposals

On the ballot3

  1. 1

    Election of Directors

    ManagementBoard: FOR

    Election of three Class I directors to the board (Beiser, Carter, Zuber) with Dr. Kosecoff’s term expiring; board will be reduced to ten directors.

  2. 2

    Advisory Vote on Executive Compensation

    ManagementBoard: FOR

    Non-binding advisory vote on the compensation of named executive officers as disclosed in the Proxy Statement.

  3. 3

    Ratification of Independent Auditor

    ManagementBoard: FOR

    ratification of KPMG LLP as Houlihan Lokey, Inc.’s independent registered public accounting firm for the fiscal year ending March 31, 2026.

Director elections

Nominees on the ballot3

Independent
Tenure on this board
35.5 yrs
Also a director at
Palomar Holdings Inc (PLMR)
Ownership

Top institutional holders10

Latest 13F quarter
1BlackRock, Inc.4.6%3,174,853$456M
2VANGUARD PORTFOLIO MANAGEMENT LLC4.0%2,778,410$399M
3VANGUARD CAPITAL MANAGEMENT LLC3.5%2,419,332$347M
4EARNEST PARTNERS LLC3.2%2,228,984$320M
5KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC2.5%1,713,248$246M
6STATE STREET CORP2.5%1,693,696$243M
7ROYAL BANK OF CANADA2.4%1,646,309$236M
8BlackRock, Inc.2.4%1,639,154$235M
9Capital Research Global Investors1.9%1,314,674$189M
10GEODE CAPITAL MANAGEMENT, LLC1.7%1,146,717$165M
Filings

Recent key filings

Periodic reports
Definitive proxies
Reference

Frequently asked questions

When is the Houlihan Lokey Inc 2025 annual meeting?
Houlihan Lokey Inc (HLI) holds its 2025 annual shareholder meeting on Wednesday, September 17, 2025.
What is the record date for the Houlihan Lokey Inc 2025 meeting?
The record date for the Houlihan Lokey Inc 2025 meeting is Thursday, July 24, 2025. Shareholders of record on or before that date are eligible to vote.
Who are the director nominees for Houlihan Lokey Inc's 2025 meeting?
The board is presenting 3 director nominees at the Houlihan Lokey Inc 2025 meeting, listed with their independence status and background.
What proposals will shareholders vote on at the Houlihan Lokey Inc 2025 meeting?
Shareholders will vote on 3 proposals at the Houlihan Lokey Inc 2025 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer